Beyond neurodegeneration:engineering amyloids for biocatalysis  

作　　者：Andrea Bartolomé-Nafría Javier García-Pardo Salvador Ventura 

机构地区：[1]Institut de Biotecnologia i de Biomedicina(IBB)and Departament de Bioquímica i Biologia Molecular,Universitat Autònoma de Barcelona,Bellaterra,Barcelona,Spain [2]Hospital Universitari Parc Taulí,Institut d’Investigaciói InnovacióParc Taulí(I3PT-CERCA),Universitat Autònoma de Barcelona,Sabadell,Spain

出　　处：《Neural Regeneration Research》2025年第10期2915-2916,共2页中国神经再生研究（英文版）

摘　　要：Amyloid fibrils are highly organized protein or peptide aggregates,often characterized by a distinctive supramolecular cross-β-sheet structure.The formation and accumulation of these structures have been traditionally associated with neural or systemic human diseases,such as Alzheimer’s disease,Parkinson’s disease,type-2 diabetes,or amyotrophic lateral sclerosis(Wei et al.,2017;Wittung-Stafshede,2023).

关 键 词：structure AMYLOID 

分 类 号：R338[医药卫生—人体生理学]